Raymond S Koff

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. ncbi Hepatitis vaccines: recent advances
    Raymond S Koff
    Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA
    Int J Parasitol 33:517-23. 2003
  2. ncbi Risks associated with hepatitis A and hepatitis B in patients with hepatitis C
    R S Koff
    University of Massachusetts Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Clin Gastroenterol 33:20-6. 2001
  3. ncbi Immunogenicity of hepatitis B vaccines: implications of immune memory
    Raymond S Koff
    Department of Medicine, University of Massachusetts Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    Vaccine 20:3695-701. 2002
  4. ncbi Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [Science 1973;182:1026-1028]
    Raymond S Koff
    Department of Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Hepatol 37:2-6. 2002
  5. ncbi Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update
    Raymond S Koff
    Department of Medicine, University of Massachusetts Medical School, Worcester, USA
    Dig Dis Sci 47:1183-94. 2002
  6. ncbi The therapeutic use of acetaminophen in patients with liver disease
    Gordon D Benson
    Department of Medicine, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 401 Haddon Avenue, Camden, NJ 08103, USA
    Am J Ther 12:133-41. 2005
  7. ncbi An economic assessment of pre-vaccination screening for hepatitis A and B
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Public Health Rep 118:550-8. 2003
  8. ncbi Re: Arguedas et al.--Hepatitis A prevention analysis
    R Jake Jacobs
    Am J Gastroenterol 97:2924-5; author reply 2925. 2002
  9. ncbi The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    Am J Gastroenterol 97:427-34. 2002
  10. ncbi Regional variation in the cost effectiveness of childhood hepatitis A immunization
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 22:904-14. 2003

Detail Information

Publications12

  1. ncbi Hepatitis vaccines: recent advances
    Raymond S Koff
    Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA
    Int J Parasitol 33:517-23. 2003
    ..Advances in recombinant technology, the use of novel genetic (DNA-based) vaccines, expression of hepatitis antigens in plants and improved adjuvants also hold considerable promise...
  2. ncbi Risks associated with hepatitis A and hepatitis B in patients with hepatitis C
    R S Koff
    University of Massachusetts Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Clin Gastroenterol 33:20-6. 2001
    ....
  3. ncbi Immunogenicity of hepatitis B vaccines: implications of immune memory
    Raymond S Koff
    Department of Medicine, University of Massachusetts Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01655, USA
    Vaccine 20:3695-701. 2002
    ..Antigen persistence may be related to antigen content of the vaccine and thereby influences the duration of immunity. Proof of this concept will require additional studies of immune memory in HBV...
  4. ncbi Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [Science 1973;182:1026-1028]
    Raymond S Koff
    Department of Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
    J Hepatol 37:2-6. 2002
  5. ncbi Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis: an update
    Raymond S Koff
    Department of Medicine, University of Massachusetts Medical School, Worcester, USA
    Dig Dis Sci 47:1183-94. 2002
    ..Although commercially available vaccines for hepatitis C, D, and E remain a distant goal, advances in vaccine and adjuvant technology, including immunization with DNA-based vaccines, hold promise for the future...
  6. ncbi The therapeutic use of acetaminophen in patients with liver disease
    Gordon D Benson
    Department of Medicine, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 401 Haddon Avenue, Camden, NJ 08103, USA
    Am J Ther 12:133-41. 2005
    ....
  7. ncbi An economic assessment of pre-vaccination screening for hepatitis A and B
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Public Health Rep 118:550-8. 2003
    ....
  8. ncbi Re: Arguedas et al.--Hepatitis A prevention analysis
    R Jake Jacobs
    Am J Gastroenterol 97:2924-5; author reply 2925. 2002
  9. ncbi The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    Am J Gastroenterol 97:427-34. 2002
    ..Consistent with other medical interventions for chronic hepatitis C patients, cost-effectiveness is most favorable for younger patients...
  10. ncbi Regional variation in the cost effectiveness of childhood hepatitis A immunization
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 22:904-14. 2003
    ..Routine childhood hepatitis A immunization is recommended in regions with incidence rates twice the national average, but it may be cost-effective in a wider geographic area...
  11. ncbi Fulminant hepatitis A: Disappearing, but not soon enough
    Raymond S Koff
    Hepatology 44:1397-9. 2006
  12. ncbi Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B
    Emmet B Keeffe
    Stanford University School of Medicine, Stanford, California 94304 1509, USA
    Clin Gastroenterol Hepatol 5:890-7. 2007
    ..Future studies of the use of the roadmap concept in improving outcomes of chronic hepatitis B are warranted...